| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer. | Breast Cancer Res | 2010 | 1.65 |
| 2 | WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. | Cancer Res | 2009 | 1.25 |
| 3 | Progressive loss of estrogen receptor alpha cofactor recruitment in endocrine resistance. | Mol Endocrinol | 2007 | 0.91 |